Craneware (FRA:3X6) ROCE %: 7.27% (As of Dec. 2025)

What is Craneware ROCE %?

Craneware FRA:3X6 -3.73% 84 ROCE % is 7.27% as of Dec. 2025. GuruFocus rates FRA:3X6 with a GF Score™ of 84/100 and a GF Value™ of €24.55 (Significantly Undervalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Craneware's annualized ROCE % for the quarter that ended in Dec. 2025 was 7.27%.

Craneware (FRA:3X6) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Craneware ROCE % Related Terms

Craneware ROCE % Historical Data

* Premium members only.

The historical data trend for Craneware's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Craneware ROCE % Chart

Craneware Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

ROCE %

Get a 7-Day Free Trial

7.85

5.05

4.09

4.96

6.73

Craneware Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
ROCE %	Get a 7-Day Free Trial															3.99	6.01	6.01	7.55	7.27

84GF Score

Craneware PLC FRA:3X6

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Craneware ROCE % Calculation

Craneware's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2025 )		(A: Jun. 2024 )		(A: Jun. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2025 )		(A: Jun. 2024 )		(A: Jun. 2025 )
	=	23.147	/	( ( (505.055 - 138.199)	+	(477.769 - 157.022) )	/ 2 )
	=	23.147	/	( (366.856	+	320.747)	/ 2 )
	=	23.147	/	343.8015
	=	6.73 %

Craneware's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2025 )		(Q: Jun. 2025 )		(Q: Dec. 2025 )
	=	23.832	/	( ( (477.769 - 157.022)	+	(448.832 - 113.914) )	/ 2 )
	=	23.832	/	( ( 320.747	+	334.918 )	/ 2 )
	=	23.832	/	327.8325
	=	7.27 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 7.27% mean?

Craneware (FRA:3X6) has a ROCE % of 7.27% as of Dec. 2025.

Is Craneware's ROCE % too high?

Craneware's current ROCE % is 7.27%. The Healthcare Providers & Services industry median ROCE % is 6.43. Craneware's value of 7.27% is 13.1% above this industry median. Overall, Craneware has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Craneware's ROCE % compare to VEEV and BTSG?

Craneware's ROCE % of 7.27% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. Craneware's value of 7.27% is 13.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Healthcare Providers & Services company?

The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Craneware's current ROCE % of 7.27% is 13.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Craneware's current ROCE % is 7.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Craneware stock overvalued right now?

Based on GuruFocus' analysis, Craneware (FRA:3X6) is currently considered Significantly Undervalued. The stock's GF Value™ is €24.55, compared to a current price of €15.50 — trading 36.9% below its estimated fair value. The current ROCE % is 7.27% and 13.1% above the Healthcare Providers & Services industry median of 6.43. Craneware's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Craneware (FRA:3X6), the current ROCE % is 7.27% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Craneware (FRA:3X6) Overvalued in 2026?

Based on GuruFocus' analysis, Craneware stock appears to be undervalued. The current stock price of €15.50 is trading 36.9% below its estimated GF Value™ of €24.55. GuruFocus considers Craneware to be Significantly Undervalued.

Key valuation signals for FRA:3X6:

ROCE %: 7.27%
GF Value™: €24.55 vs. price of €15.50 (36.9% below fair value)
GF Score™: 84/100 with 7 warning signs
Industry Position: 13.1% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:3X6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Craneware Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies LSE:OPT LSE:DXRX LSE:KOO LSE:COG LSE:MPAL LSE:RENX LSE:FDBK LSE:IBAI AQSE:DXSP LSE:TRLS VEEV BTSG ASX:PME TEM HQY TSE:2413 HKSE:02228 HNGE DOCS WAY

Other Exchanges CRWl:UK CRW:UK

Address 1 Tanfield, Edinburgh, GBR, EH3 5DA

Website https://www.thecranewaregroup.com

Craneware PLC provides automated revenue integrity solutions that improve financial performance for healthcare organizations. Its activities include the development, licensing, and ongoing support of computer software for the US healthcare industry. It is engaged in the sale of software licenses, white labelling, and professional services (including installation) to hospitals within the USA. The company recognizes its revenues from the sale of and distribution agreements relating to software licenses and professional services.

84GF Score

Get the complete analysis for FRA:3X6

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.50

Price

€24.55

GF Value

View FRA:3X6 Analysis

See ROCE % data for all stocks →